Terms: = Breast cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
62 results:
1. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Ma R; Guan X; Teng N; Du Y; Ou S; Li X
BMC Med Genomics; 2023 Oct; 16(1):254. PubMed ID: 37864213
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and prognosis of postpartum breast cancer.
Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
Song YC; Kong J; Li N; Liu XL; Li XH; Zhu LY; Wang YW; Fang H; Jing H; Tang Y; Li YX; Wang XH; Zhang J; Wang SL
Radiother Oncol; 2023 Jun; 183():109639. PubMed ID: 36990395
[TBL] [Abstract] [Full Text] [Related]
4. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
5. Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity.
Fu Z; Chen S; Zhu Y; Zhang D; Xie P; Jiao Q; Chi J; Xu S; Xue Y; Lu X; Song X; Cristofanilli M; Gradishar WJ; Kalinsky K; Yin Y; Zhang B; Wan Y
Sci Adv; 2023 Jan; 9(1):eadd6626. PubMed ID: 36608132
[TBL] [Abstract] [Full Text] [Related]
6. Impact of breath-hold technique on incidence of cardiac events in adjuvant left breast cancer irradiation.
Mahmoud AA; Sadaka EA; Abouegylah M; Amin SA; Elmansy H; Asal MF; Köksal MA; Gawish A
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5853-5859. PubMed ID: 36585984
[TBL] [Abstract] [Full Text] [Related]
7. Neuroendocrine pathways and breast cancer progression: a pooled analysis of somatic mutations and gene expression from two large breast cancer cohorts.
Hu K; Wang C; Luo C; Zheng H; Song H; Bergstedt J; Fall K; Luo T; Czene K; Valdimarsdóttir UA; Fang F; Lu D
BMC Cancer; 2022 Jun; 22(1):680. PubMed ID: 35729536
[TBL] [Abstract] [Full Text] [Related]
8. Platelet-Derived miR-126-3p Directly Targets akt2 and Exerts Anti-Tumor Effects in breast cancer Cells: Further Insights in Platelet-cancer Interplay.
Sibilano M; Tullio V; Adorno G; Savini I; Gasperi V; Catani MV
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628294
[TBL] [Abstract] [Full Text] [Related]
9. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract] [Full Text] [Related]
10. Retrospective literature review of primary neuroendocrine neoplasms of the breast (BNEN) in 209 Chinese patients: Treatment and prognostic factor analysis.
Chai Y; Liu M; Li Z; Chen Y; Qi F; Li Q; Xu B
Breast; 2022 Apr; 62():93-102. PubMed ID: 35134665
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and prognosis in Patients with breast cancer.
Peddi PF; Fasching PA; Liu D; Quinaux E; Robert NJ; Valero V; Crown J; Falkson C; Brufsky A; Cunningham JM; Weinshilboum RM; Pienkowski T; Eiermann W; Martín M; Bee V; Wang X; Wang L; Yang E; Slamon DJ; Hurvitz SA
Clin Cancer Res; 2022 May; 28(9):1854-1862. PubMed ID: 35110416
[TBL] [Abstract] [Full Text] [Related]
12. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA
Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428
[TBL] [Abstract] [Full Text] [Related]
13. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Yu Y; Xie Z; Zhao M; Lian X
BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
[TBL] [Abstract] [Full Text] [Related]
14. The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte.
Han B; Dong L; Zhou J; Yang Y; Guo J; Xuan Q; Gao K; Xu Z; Lei W; Wang J; Zhang Q
Cancer Immunol Immunother; 2021 Oct; 70(10):2893-2909. PubMed ID: 33688997
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis.
Zhang G; Li C; Tian G; Cheng X; Li Y; Ma L
Medicine (Baltimore); 2020 Dec; 99(52):e23593. PubMed ID: 33350734
[TBL] [Abstract] [Full Text] [Related]
16. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Lin H; Wu Y; Liang G; Chen L
PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
[TBL] [Abstract] [Full Text] [Related]
17. Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado cancer Center.
Weiss JA; Nicklawsky A; Kagihara JA; Gao D; Fisher C; Elias A; Borges VF; Kabos P; Davis SL; Leong S; Eckhardt SG; Diamond JR
Cancer Med; 2020 Dec; 9(23):8801-8808. PubMed ID: 33063469
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract] [Full Text] [Related]
19. Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.
Kanwar N; Carmine-Simmen K; Nair R; Wang C; Moghadas-Jafari S; Blaser H; Tran-Thanh D; Wang D; Wang P; Wang J; Pasculescu A; Datti A; Mak T; Lewis JD; Done SJ
EBioMedicine; 2020 Feb; 52():102646. PubMed ID: 32062352
[TBL] [Abstract] [Full Text] [Related]
20. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
[TBL] [Abstract] [Full Text] [Related]
[Next]
